艾媒咨询 | 2026年中国夜间用药市场研究报告|2026年中国夜间用药市场研究报告|医疗保健|艾媒咨询|药品|零售

近年来，中国夜间用药市场持续受益于夜间经济、即时零售、24小时药店、在线问诊及健康消费升级等多重赋能，其服务形态已从单一的线下药店夜间售药延伸至线上购药、即时配送、用药咨询与健康管理等多场景融合。全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2026年中国夜间用药市场研究报告》数据显示，中国农村居民人均医疗保健消费支出从2013年的1627元增长至2025年的4306元，13年间持续攀升；医疗保健类城市居民消费价格指数在2016年至2025年间始终保持正增长，2025年较上年上涨0.5%。居民医疗保健消费能力与价格水平同步上行，为夜间用药市场扩容提供了坚实支撑。

2026年中国消费者夜间线下药店购药时遇到的困难中，夜间出行不便占比最高，达46.39%；其次是附近无24小时药店需远行，占40.29%；无专业人员指导用药、药店无所需药品占比均接近三成；药品价格偏高、服务态度差也占据一定比例；仅1.92%表示无明显困难。线下夜间购药在可达性、药品可及性与专业服务方面仍存在明显短板，24小时药店覆盖不足与夜间出行成本高是制约线下消费的主要瓶颈。

2026年中国消费者夜间线上购药遇到的问题中，配送速度太慢占比最高，达32.68%；个人隐私泄露占29.68%；无专业用药指导占28.52%；药品质量有问题占28.06%；平台售后不完善占27.02%；配送费用过高占25.64%；无所需药品占23.79%；配送过程中药品破损占21.02%；仅5.43%从未遇到过问题。线上购药虽便捷，但配送时效、隐私安全、用药指导与质量保障等问题分布多元，用户体验仍有较大提升空间。

艾媒咨询分析师认为，夜间线上购药的用户体验仍有较大提升空间，问题分布较为多元，涉及配送、质量、服务、售后等多个环节。其中配送时效仍是最突出的痛点，说明当前的配送能力还不能完全满足所有场景的应急需求；药品质量与用药指导问题则关乎用药安全，是行业必须守住的底线。建议相关平台优化夜间运力调度与前置仓布局，强化药师在线审方与用药咨询能力，完善隐私保护与售后保障机制，并推动24小时药店与即时零售平台协同发展，以安全、便捷、专业的服务满足夜间应急用药需求。未来，随着夜间健康消费持续释放与即时零售生态完善，夜间用药市场仍具备强劲的增长潜力与规范化升级空间。

In recent years, China's nighttime medication market has continuously benefited from multiple enabling factors, including the nighttime economy, instant retail, 24-hour pharmacies, online consultations, and the upgrading of health consumption. Its service models have evolved from solely offline pharmacy nighttime drug sales to integrated multi-scenario approaches encompassing online drug purchasing, instant delivery, medication consultation, and health management. According to data from the latest "2026 China Nighttime Medication Market Research Report" released by iiMedia Research—a globally leading third-party data mining and analysis institution for new economic industries—the per capita healthcare expenditure among rural residents in China rose from 1,627 yuan in 2013 to 4,306 yuan in 2025, demonstrating a steady increase over the 13-year period. The consumer price index for healthcare among urban residents also maintained positive growth from 2016 to 2025, with a 0.5% year-on-year increase in 2025. The concurrent rise in residents' healthcare spending capacity and price levels has provided solid support for the expansion of the nighttime medication market.

In 2026, the most common difficulties encountered by Chinese consumers when purchasing medication at offline pharmacies during nighttime were inconvenient nighttime travel, accounting for 46.39% of responses; followed by the absence of nearby 24-hour pharmacies requiring long trips, accounting for 40.29%; the lack of professional medication guidance and the absence of required medications in pharmacies each accounted for nearly 30%; relatively high medication prices and poor service attitudes also constituted a significant proportion; only 1.92% of respondents reported no obvious difficulties. Offline nighttime medication purchases still face notable shortcomings in accessibility, medication availability, and professional services, with insufficient coverage of 24-hour pharmacies and high nighttime travel costs being the primary bottlenecks constraining offline consumption. In 2026, among the issues encountered by Chinese consumers when purchasing medications online during nighttime hours, slow delivery speed accounted for the highest proportion at 32.68%; personal privacy leakage accounted for 29.68%; lack of professional medication guidance accounted for 28.52%; concerns about medication quality accounted for 28.06%; inadequate after-sales service on platforms accounted for 27.02%; excessively high delivery costs accounted for 25.64%; absence of needed medications accounted for 23.79%; damage to medications during delivery accounted for 21.02%; only 5.43% of consumers had never encountered any issues. Although online medication purchasing offers convenience, challenges such as delivery timeliness, privacy security, medication guidance, and quality assurance remain diverse, indicating significant room for improving user experience.

Analysts at iiMedia Research believe that the user experience for nighttime online medication purchases still has considerable room for improvement, with issues spanning multiple aspects including delivery, quality, service, and after-sales support. Among these, delivery timeliness remains the most prominent pain point, suggesting that current delivery capabilities cannot fully meet emergency needs across all scenarios; concerns regarding medication quality and professional guidance, however, relate to medication safety—a critical baseline that the industry must uphold. It is recommended that relevant platforms optimize nighttime delivery capacity allocation and the layout of front-end warehouses, enhance pharmacists' capabilities in online prescription review and medication consultation, refine privacy protection and after-sales safeguard mechanisms, and foster collaborative development between 24-hour pharmacies and instant retail platforms, thereby meeting nighttime emergency medication needs with safe, convenient, and professional services. In the future, as nighttime health consumption continues to grow and the instant retail ecosystem matures, the nighttime medication market is poised to exhibit strong growth potential and opportunities for standardized upgrading.